Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized Trials.

Cancer Res Treat · 2025 · PMC12016839 · PMID 39438001

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

Due to the small sample size, especially for the mFOLFOX and mFOLFIRI groups, and the marginal significance in the multivariable analyses for nal-IRI plus 5-FU/LV vs. mFOLFIRI or mFOLFOX, the results of this analysis are not conclusive and further investigations are necessary.

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.